INTRODUCTION
Inflammation, defined as the immune system response to injury or infection, is a protective response that leads to the removal of initiating noxious stimuli or offending factors and the restoration of tissue structures and physiological functions. However, excessive chronic inflammation represents the basis of severe diseases including inflammatory bowel disease, arthritis, asthma, cancer, atherosclerosis, Alzheimer's disease, and Parkinson's disease (1) (2) (3) (4) (5) . Therefore, controlling the inflammatory responses is important to prevent and treat many diseases. Nitric oxide (NO), a gaseous free radical, and prostaglandin E2 (PGE2), an eicosanoid derived from arachidonic acid, have been identified as important biological molecules involved in the immune responses and inflammation (6, 7) . Upon inflammatory stimulation, large amounts of NO and PGE 2 produced by inducible NO synthases (iNOS) and cyclooxygenase 2 (COX-2), respectively, induce substantial inflammatory response and related processes (6, 8) . Therefore, the regulation of NO production and PGE2 generation is the "gold standard" for the prevention and treatment of many inflammatory diseases.
Ixeris dentata Nakai (IDN) has been used as a traditional herbal medicine in East Asian countries to treat indigestion, pneumonia, hepatitis, contusions, and tumors (9) . Previous studies reported that IDN exhibits multiple pharmacological activities including antidiabetic, anticolitic, antiallergic, and neuroprotective properties (10) (11) (12) (13) (14) (15) . Furthermore, it has been reported that the IDN water extract possesses an anti-inflammatory activity against 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin inflammation (16) . Previous studies demonstrated that several biologically active compounds including sesquiterpene lactones and flavonoids isolated from Ixeris dentate possesses multiple pharmacological activities on cancer (9, 17) , acylcoenzyme A: cholesterol acyltransferase (ACAT) activity (9) , and inflammation (13, 18, 19) . While the anti-inflammatory activities of IDN and its bio-active compounds have been reported previously, the effect of IDN on the production of pro-inflammatory mediators including PGE 2 and NO has not yet been fully studied. Thus, in the present study, we evaluated the inhibitory properties of IDN methanol extract (MeOH-ex) and its solvent fractions on NO production and PGE2 generation in a murine macrophagelike cell line RAW264.7, which can be activated with LPS to induce pro-inflammatory mediators.
MATERIALS AND METHODS
Plant material, extraction, and fractionation The IDN was purchased from the local herbal market (Asan, Chungnam, Korea) and verified at the Department of Plant Resources, Soonchunhyang University (Asan, Chungnam, Korea). The air-dried IDN (2 kg) was powdered and exhaustively extracted with 99.8% MeOH (3× 1.5 L) at room temperature for 48 h. The solution was filtered and concentrated under reduced pressure on a rotatory evaporator at 45 o C, resulting in 205.8 g of crude MeOH-ex. The entire MeOH-ex (200 g) was suspended in 0.5 L of water and then partitioned sequentially with equal volumes of hexane (n-hexane), chloroform (CHCl 3 ), and ethyl acetate (EtOAc). Each fraction was evaporated in vacuo to yield the residues of n-hexane, CHCl3, and EtOAc fractions. The MeOH-ex and the three fractions were tested for inhibitory effects against NO and PGE2 generation by using a murine macrophage cell line, RAW264.7.
Cell culture RAW264.7 cells, obtained from American Type Culture Collection (Manassas, VA, USA), were cultured in DMEM (Gibco-BRL, Grand Island, NY, USA) supplemented with 10% heat-inactivated FBS, 100 U/mL of penicillin, and 100 μg/mL streptomycin at 37 o C under humidified air containing 5% CO 2 inside an incubator. Cells were plated in 35-mm culture dishes at a density of 6×10 5 cells/dish for the following experiments.
NO assay RAW264.7 cells were plated at a density of 2×10 4 cells/well in 96-well plates, and then stimulated with or without LPS (1 μg/mL) in the absence or presence of various concentrations of testing samples for 24 h. The nitrite accumulation in the supernatant was assessed by the Griess reaction (20) . Each 50 μL of culture supernatant was mixed with an equal volume of Griess reagent (0.1% N-(1-naphthyl)-ethylenediamine and 1% sulfanilamide in 5% phosphoric acid) and incubated at room temperature for 10 min. The absorbance at 550 nm was measured using an automated microplate reader and a series of known concentrations of sodium nitrite was used as the standard.
Measurement of PGE 2 generation RAW264.7 cells were plated at a density of 2×10 4 cells/ well in 96-well plates, and then stimulated with or without LPS (1 μg/mL) in the absence or presence of various concentrations of testing samples for 24 h. Vehicle (DMSO) only cultures served as controls. Cell culture supernatants were harvested and the generation of PGE 2 in cell culture was measured using commercial ELISA kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions.
Cell viability assay
The cytotoxic effect of the various samples after 24 h of incubation was evaluated in the cells using the MTT assay to determine the appropriate concentration that is not cytotoxic to the cells. Briefly, RAW264.7 cells were plated at a density of 2×10 4 cells/well in 96-well plates and then treated with various concentrations of testing sample. Following incubation for 24 h, the culture medium was removed and replaced with 100 μL of fresh medium, and then 20 μL of 0.5 mg/mL MTT solution was added to each well. After incubation for 1.5 h, the medium with MTT was removed and 200 μL of DMSO was added to each well. The plates were then gently agitated until the color reaction was uniform and the colorimetric evaluation was performed with a microplate reader at 540 nm.
Western blot analysis
Whole cell lysates were obtained as previously described (21) . SDS-PAGE and western blot analysis were performed as described previously (21, 22) . Briefly, the cells were cultured in 6-well culture plates at a density of 5×10 5 cells/well for 24 h. The cells were then stimulated with or without LPS (1 μg/mL) in the absence or presence of various concentrations of testing samples for 24 h. The cells were washed twice with PBS, lysed, and the proteins were separated on 10% to 15% SDS-PAGE. The proteins were transferred to polyvinylidene fluoride (PVDF) membrane, and membranes were blocked with 5% skim milk in TBST-buffer for 2.5 h at room temperature. The protein-transfer membranes were probed with the following primary antibodies: mouse monoclonal antibodies directed against rabbit polyclonal antibodies directed against iNOS (1:500, Santa Cruz Biotechnology, Dallas, TX, USA) and COX-2 (1:500, Santa Cruz Biotechnology). Protein expression was visualized using a chemiluminescence reagent (Amersham Pharmacia Biotech, Inc., Buckinghamshire, UK), and detected using a digital chemiluminescence imaging system equipped with a charge coupled device (CCD) camera (Fusion-FX, Fisher BioTec Ltd., Wembley, Australia).
Statistical analysis
Statistical analyses were carried out using the GraphPad Prism 5.0 software (GraphPad Software Inc., La Jolla, CA, USA). Pairwise comparisons were performed using oneway ANOVA Dunnett's tests. Data are presented as mean± SEM in the indicated number of experiments. The differences between groups were considered significant at p-value below 0.05.
RESULTS AND DISCUSSION
IDN EtOAc fraction potently inhibits NO production and PGE2 generation in LPS-stimulated RAW264.7 cells One hallmark of chronic inflammation is the continuous recruitment and activation of macrophages to the sites of inflammation. Macrophages play a central role in inflammatory responses through phagocytosis, antigen presentation, and immunomodulation (23) . Activated macrophages produce a wide variety of pro-inflammatory mediators, such as NO and PGE 2 which are generated by iNOS and COX-2, respectively (24) . Excessive release of these pro-inflammatory mediators from activated macrophages has long been recognized as a risk factor for inflammatory diseases (25) . To evaluate the anti-inflammatory property of IDN, we initially evaluated the effect of IDN MeOH-ex and its solvent fractions on LPS-induced NO production in murine macrophage-like cell line, RAW264.7. In contrast to the LPS control group, IDN MeOH-ex treatment significantly inhibited the LPS-induced NO production in a concentration-dependent manner (Fig. 1A) . We further found that treatment with n-hexane fraction (n-hexane-fr, Fig. 1B ), CHCl 3 fraction (CHCl 3 -fr, Fig. 1C ), and EtOAc fraction (EtOAc-fr, Fig. 1D ) effectively inhibited NO production in a concentration-dependent manner with IC50 values of 102.6, 87.8, and 16.4 μg/mL, respectively. In addition, we observed that the LPS-induced PGE2 generation in RAW264.7 cells was also significantly decreased by n-hexane-fr (Fig. 2B) , CHCl 3 -fr (Fig. 2C) , and EtOAcfr ( Fig. 2D) with IC50 values of 94.4, 123.7, and 85.8 μg/ mL, respectively, while MeOH-ex showed a non-dose-dependent inhibitory activity ( Fig. 2A) . Our results indicated that the IDN EtOAc-fr has a potent inhibitory activity on LPS-stimulated inflammatory responses in macrophages. Previous studies have also reported that TNF-α, IL-6, and IL-1β levels were significantly lowered by IDN water extract treatment in acute colitis and dermatitis (12, 16) . Taken together, these results suggested that the IDN extract possessed an effective anti-inflammatory property against multiple inflammatory responses.
IDN EtOAc fraction effectively suppresses iNOS and COX-2 expression in LPS-stimulated RAW264.7 cells
Since EtOAc-fr was identified to have the most potent anti-inflammatory property against LPS-induced inflamma- tion, we further evaluated its anti-inflammatory mechanism.
Previously, it has been demonstrated that treatment with IDN water extract effectively reduced the expression of pro-inflammatory proteins, such as NF-κB and MAPKs (12, 16, 18) , but the effects of IDN MeOH-ex and its solvent fractions on the expression of pro-inflammatory proteins regulating NO production and PGE2 generation have not been extensively investigated. To investigate the possible mode of action, we tested the effect of IDN EtOAc-fr on iNOS and COX-2 expression in LPS-stimulated RAW264.7 cells. Stimulation with LPS upregulated the expression of iNOS and COX-2 in cells compared with the unstimulated controls. We found that treatment of cells with IDN EtOAc-fr significantly suppressed LPS-induced iNOS expression in a dose-dependent manner (Fig. 3A) . This result suggests that the IDN EtOAc-fr inhibits LPSinduced NO production and PGE 2 generation through suppression of iNOS and COX-2 expression. To examine whether the anti-inflammatory activity of IDN EtOAc-fr in RAW264.7 cells is attributable to its cytotoxicity, we examined the effect of IDN EtOAc-fr treatment on cell viability. Importantly, an MTT assay using RAW264.7 cells treated with IDN EtOAc-fr alone (up to 200 μg/mL) showed that the cell morphology (Fig. 3D ) and cell viability (Fig. 3E) were not significantly altered. These results demonstrated that IDN EtOAc-fr exhibited anti-inflammatory activity without affecting cell viability.
In conclusion, we identified the EtOAc-fr of IDN MeOH-ex as an anti-inflammatory substance that effectively inhibited LPS-induced NO production and PGE2 generation by suppressing iNOS and COX-2 expressions in RAW264.7 cells. Therefore, the bioactive components of IDN EtOAc-fr may be promising natural anti-inflammatory compounds for the prevention and treatment of multiple inflammatory diseases. Further studies are required to identify the bioactive compounds of IDN.
